<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35317885</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1539-6304</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Allergy and asthma proceedings</Title><ISOAbbreviation>Allergy Asthma Proc</ISOAbbreviation></Journal><ArticleTitle>Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.</ArticleTitle><Pagination><StartPage>93</StartPage><EndPage>95</EndPage><MedlinePgn>93-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2500/aap.2022.43.220008</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellanti</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Settipane</LastName><ForeName>Russell A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Allergy Asthma Proc</MedlineTA><NlmUniqueID>9603640</NlmUniqueID><ISSNLinking>1088-5412</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Allergy Asthma Proc. 2022 Mar 1;43(2):155-162. doi: 10.2500/aap.2022.43.220005</RefSource><PMID Version="1">35317893</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000072223" MajorTopicYN="N">Allergists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35317885</ArticleId><ArticleId IdType="pmc">PMC8984762</ArticleId><ArticleId IdType="doi">10.2500/aap.2022.43.220008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Phillips S, Williams MA. Confronting our next national health disaster - long-haul COVID. N Engl J Med. 2021; 385:577&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Helman SN, Adler J, Jafari A, et al. . Treatment strategies for postviral olfactory dysfunction: a systematic review. Allergy Asthma Proc. 2022; 43:96&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8984764</ArticleId><ArticleId IdType="pubmed">35317886</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzer C, Karadag P, Yegit O, et al. . Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19. Allergy Asthma Proc. 2022; 43:106&#x2013; 115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8984761</ArticleId><ArticleId IdType="pubmed">35317887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez RM, V RL, Andrews CP. Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber. Allergy Asthma Proc. 2022; 43:116&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317888</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, Hu H, Zhang T, et al. . Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (&gt;1000 kU/L). Allergy Asthma Proc. 2022; 43:124&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317889</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HS, Yang H-J, Song DJ, et al. . Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children. Allergy Asthma Proc. 2022; 43:133&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozden Sertcelik U, Damadoglu E, Karakaya G, et al. . Impact of socioeconomic factors and house cleaning on asthma control in women. Allergy Asthma Proc. 2022; 43:140&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317891</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning ME. Hereditary angioedema: differential diagnosis, diagnostic tests, and family screening. Allergy Asthma Proc. 2020; 41(suppl 1):S22&#x2013;S25.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109321</ArticleId></ArticleIdList></Reference><Reference><Citation>Azmy V, Brooks JP, Hsu FI. Clinical presentation of hereditary angioedema. Allergy Asthma Proc. 2020; 41(suppl 1):S18&#x2013;S21.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedner HJ. Hereditary angioedema: pathophysiology (HAE type I, HAE type II, and HAE nC1-INH). Allergy Asthma Proc. 2020; 41(suppl 1):S14&#x2013;S17.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109319</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumry WR, Settipane RA. Hereditary angioedema: epidemiology and burden of disease. Allergy Asthma Proc. 2020; 41(suppl 1):S08&#x2013;S13.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109318</ArticleId></ArticleIdList></Reference><Reference><Citation>Proper SP, Lavery WJ, Bernstein JA. Definition and classification of hereditary angioedema. Allergy Asthma Proc. 2020; 41(suppl 1):S03&#x2013;S07.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109317</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachdjian R, Johnson KE, Casso D, et al. . Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States. Allergy Asthma Proc. 2020; 41:172&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">32375961</ArticleId></ArticleIdList></Reference><Reference><Citation>Girolami A, Rolland C, Sexton D, et al. . Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: a systematic literature review of case reports. Allergy Asthma Proc. 2020; 41:10&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">31888778</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon TL, Kalina U, Laske R, et al. . Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema. Allergy Asthma Proc. 2020; 41:99&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">31796151</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarese L, Mormile I, Bova M, et al. . Psychology and hereditary angioedema: a systematic review. Allergy Asthma Proc. 2021; 42:e1&#x2013;e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7768073</ArticleId><ArticleId IdType="pubmed">33404395</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston DT, Henry Li H, Craig TJ, et al. . Androgen use in hereditary angioedema: a critical appraisal and approaches to transitioning from androgens to other therapies. Allergy Asthma Proc. 2021; 42:22&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">33349293</ArticleId></ArticleIdList></Reference><Reference><Citation>Settipane RA, Bukstein DA, Riedl MA. Hereditary angioedema and shared decision making. Allergy Asthma Proc. 2020; 41(suppl 1):S55&#x2013;S60.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109329</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan AP. Hereditary angioedema: investigational therapies and future research. Allergy Asthma Proc. 2020; 41(suppl 1):S51&#x2013;S54.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109328</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakaboski E, Motazedi T, Banerji A. Hereditary angioedema: special considerations in women. Allergy Asthma Proc. 2020; 41(suppl 1):S47&#x2013;S50.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109327</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston DT, Smith RC. Hereditary angioedema: special considerations in children. Allergy Asthma Proc. 2020; 41(suppl 1):S43&#x2013;S46.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109326</ArticleId></ArticleIdList></Reference><Reference><Citation>Paige D, Maina N, Anderson JT. Hereditary angioedema: comprehensive management plans and patient support. Allergy Asthma Proc. 2020; 41(suppl 1):S38&#x2013;S42.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109325</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HH. Hereditary angioedema: long-term prophylactic treatment. Allergy Asthma Proc. 2020; 41(suppl 1):S35&#x2013;S37.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109324</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig T. Triggers and short-term prophylaxis in patients with hereditary angioedema. Allergy Asthma Proc. 2020; 41(suppl 1):S30&#x2013;S34.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109323</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen SC, Zuraw BL. Hereditary angioedema: on-demand treatment of angioedema attacks. Allergy Asthma Proc. 2020; 41(suppl 1):S26&#x2013;S29.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109322</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Bostan O, Tuncay G, Damadoglu E, et al. . Effect of COVID-19 on hereditary angioedema activity and quality of life. Allergy Asthma Proc. 2021; 42:403&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8677498</ArticleId><ArticleId IdType="pubmed">34474710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocak M, Nain E, Akarsu A, et al. . Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema. Allergy Asthma Proc. 2021; 42:325&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">34187624</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson FA, Wirth M, Zhu Z, et al. . Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment. Allergy Asthma Proc. 2021; 42:317&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">34187623</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning ME, Kashkin JM. Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: review of phase II and III studies. Allergy Asthma Proc. 2021; 42:274&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">34127176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajewole O, Lanlokun M, Dimanche S, et al. . Short-term prophylaxis for children and adolescents with hereditary angioedema. Allergy Asthma Proc. 2021; 42:205&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">33980333</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedl MA, Craig TJ, Banerji A, et al. . Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs. Allergy Asthma Proc. 2021; 42(suppl 1):S17-S25.</Citation><ArticleIdList><ArticleId IdType="pubmed">33980329</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig TJ, Banerji A, Riedl MA, et al. . Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden. Allergy Asthma Proc. 2021; 42(suppl 1):S11&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pubmed">33980328</ArticleId></ArticleIdList></Reference><Reference><Citation>Radojicic C, Riedl MA, Craig TJ, et al. . Patient perspectives on the treatment burden of injectable medication for hereditary angioedema. Allergy Asthma Proc. 2021; 42(suppl 1):S4&#x2013;S10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33980327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Liu S, Zhi Y. Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema. Allergy Asthma Proc. 2021; 42:131&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8133019</ArticleId><ArticleId IdType="pubmed">33685557</ArticleId></ArticleIdList></Reference><Reference><Citation>Castaldo AJ, Jervelund C, Corcoran D, et al. . Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema. Allergy Asthma Proc. 2021; 42:108&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8133018</ArticleId><ArticleId IdType="pubmed">33581742</ArticleId></ArticleIdList></Reference><Reference><Citation>Radojicic C. Guidelines for management of hereditary angioedema: What is new? What is missing? Allergy Asthma Proc. 2022; 43:12&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">34983705</ArticleId></ArticleIdList></Reference><Reference><Citation>Grivcheva-Panovska V, Craig TJ, Longhurst H, et al. . Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management. Allergy Asthma Proc. 2022; 43:e1&#x2013;e10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8749253</ArticleId><ArticleId IdType="pubmed">34983717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chepy A, Veron M, Gautier S, et al. . Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema. Allergy Asthma Proc. 2022; 43:155&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317893</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyaz S, Demir S, Oztop N, et al. . How satisfactory is on-demand icatibant from the patients' perspective in real life? Allergy Asthma Proc. 2022; 43:148&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317892</ArticleId></ArticleIdList></Reference><Reference><Citation>Voelker DH, Gonzalez-Estrada A, Park MA. Female sex as a risk factor for penicillin drug allergy in the inpatient setting. Allergy Asthma Proc. 2022; 43:163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317894</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl KC, Popadiuk CA, Agbese E. Cost assessment of allergy procedures to improve high-value care implementation. Allergy Asthma Proc. 2022; 43:168&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317895</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>